Loading...
$ 1,000
BPC-157 with TB500 is a synergistic combination of two research peptides widely studied for their regenerative and anti-inflammatory properties. BPC-157, a gastric peptide fragment, is known for accelerating tissue repair, while TB500 (a synthetic version of Thymosin Beta-4) promotes cellular migration and angiogenesis. Together, they represent a powerful research tool for studying accelerated healing, particularly in musculoskeletal, neurological, and cardiovascular systems.
BPC-157 exerts its effects primarily by influencing the nitric oxide pathway, promoting angiogenesis, reducing inflammation, and stimulating the healing of damaged tissues. TB500 complements this by enhancing cell migration, increasing actin production, and aiding in new blood vessel formation. The combined action is theorized to produce more comprehensive regenerative outcomes than either peptide alone, particularly in tendon, ligament, and muscle injury models.
Both BPC-157 and TB500 have shown strong safety profiles in preclinical studies, with low systemic toxicity and no significant adverse events observed in animal models. There are no known carcinogenic or teratogenic effects. However, long-term safety and human data are lacking, and the compound is not approved for human use.
BPC-157 with TB500 offers a promising combination for researchers exploring enhanced recovery pathways, inflammation modulation, and tissue regeneration. The dual-peptide approach allows for investigation into potential synergistic effects in healing and cellular repair. This product is intended strictly for laboratory research purposes only and is not for human consumption under any circumstances.




(936) 931 8152
Monday – Friday 9AM – 4PM CST
Shipping Days
Mailing Address
Sign up to stay informed about our latest product releases, exclusive discounts, and in-depth product insights—delivered straight to your inbox